Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

176.00
Delayed Data
As of Oct 23
 +1.38 / +0.79%
Today’s Change
95.14
Today|||52-Week Range
177.76
+56.19%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close174.62
Today’s open174.98
Day’s range174.53 - 177.76
Volume264,493
Average volume (3 months)289,000
Market cap$7.7B
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+85.64%
Earnings growth (next 5 years)+40.50%
Revenue growth (last year)+35.13%
P/E ratio103.5
Price/Sales12.56
Price/Book16.87

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-0.01-0.02%
WSTWest Pharmaceutical ...-1.33-1.42%
MASIMasimo Corp+2.02+2.33%
IARTIntegra LifeSciences...-0.03-0.06%
Data as of 4:02pm ET, 10/23/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts